Conversely, human CRC patient‐derived tumoroids (PDTs) with active TGF‐β pathway status mostly displayed tumor‐suppressive effects, indicated by upregulation of CDK inhibitors, and in PDTs, which showed undisturbed proliferation, no signs of EMT were evident [4]. The gene discussed is TGFB1; the disease is colorectal carcinoma.